Skip to main content

01.12.2017 | Research | Ausgabe 1/2017 Open Access

International Journal for Equity in Health 1/2017

Smoking and finances: baseline characteristics of low income daily smokers in the FISCALS cohort

International Journal for Equity in Health > Ausgabe 1/2017
Kristy A. Martire, Philip Clare, Ryan J. Courtney, Billie Bonevski, Veronica Boland, Ron Borland, Christopher M. Doran, Michael Farrell, Wayne Hall, Jaimi M. Iredale, Mohammad Siahpush, Richard P. Mattick
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12939-017-0643-6) contains supplementary material, which is available to authorized users.



Financial stress is a barrier to successful smoking cessation and a key predictor of relapse. Little is known about the financial situation of low-income Australian daily smokers. This study aims to describe and investigate associations between the financial functioning, tobacco use and quitting behaviours of low income daily smokers.


Low-income Australian adult smokers in the ‘Financial Intervention for Smoking Cessation Among Low-income Smokers (FISCALS) randomised clinical trial completed a structured telephone questionnaire.


The median number of cigarettes typically smoked by the 1047 participants was 23 per day. The median spent on tobacco per week was AU$80. Three quarters (73.0%) reported some financial stress and 43.2% reported smoking-induced deprivation. Financial stress was significantly associated with deprivation (IRR: 1.23, 95% CI 1.21, 1.26, p < 0.001). There were no significant associations either between adjusted financial stress or deprivation and motivation to quit or certainty of quit success.


Financial stress and smoking induced deprivation were prevalent among low-income daily smokers, but they were not associated with motivation to quit. Smoking cessation interventions need to be responsive to the role financial stress plays in reducing quit attempts and increasing relapse.

Trial registration

Australian and New Zealand Clinical trials Registry ACTRN12612000725​864 6/07/2012
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

International Journal for Equity in Health 1/2017 Zur Ausgabe